摘要
COVID-19’s global spread has exposed the weakness of biosecurity systems,underlining shortcomings and increasing the difficulty of global governance.Given the dilemma inherent in biotechnology’s prospects and risks,the leadership of biotechnology and biosecurity capability has become a focal point of great power competition.Both the threat of bioterrorism and the risk of the misuse or abuse of biotechnology are urgent and complicated.Due to the lack of verification mechanisms and the dual-nature of biotechnology,biosecurity competition may result in an arms race or military conflict,but major powers can innovate cooperation mechanisms to provide public goods and manage risk.
基金
supported by the National Natural Science Foundation of China (Grant No.19CGJ004)。